long intergenic non-protein coding RNA 1978Genealiases: []
Q-omics provides the consensus-scored LINC01978 profile across patient tissues and cancer cell-line models. LINC01978 expression is associated with patient survival in 26 of 34 cancer types, with the highest sampling consensus in KIRP. Among the 18 cancer types available for tumor–normal comparison, LINC01978 is differentially expressed in 16, with the highest sampling consensus in COAD. Additionally, LINC01978 RNA expression shows 14,451 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight KIRP, COAD, and ESCA as cancer lineages where LINC01978 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01978 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01978 survival associations across molecular data types. LINC01978 RNA expression shows survival associations in the most cancer types (26). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01978 RNA expression–survival associations across cancer types. High LINC01978 expression shows unfavorable associations in KIRP, UVM and UCEC, but favorable associations in HNSC, STAD and MESO. The KIRP Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify KIRP as the clearest survival context for LINC01978 RNA expression.
This table summarizes LINC01978 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 16. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01978. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01978 shows lower tumor expression in KICH and HNSC and higher tumor expression in COAD, STAD, BLCA and KIRC. The COAD box plot shows higher LINC01978 RNA expression in tumor versus normal tissue (log2 FC = +1.842, t-test p < 0.001).
This table shows molecular features associated with LINC01978 in patient tissues and cancer cell lines. In patient samples, LINC01978 shows the broadest associations at the RNA and protein expression levels, with ESCA recurring as the lineage with the largest associated feature set.
